Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis

Ihara,Hiroki; Kaji,Tatsuya; Katsui,Kuniaki; Miyake,Tomoko; Waki,Takahiro; Katayama,Norihisa; Matsuzaki,Hidenobu; Yamasaki,Osamu; Kuroda,Masahiro; Morizane,Shin; Kanazawa,Susumu

doi:10.3892/mco.2019.1918

Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis

Authors:
- Hiroki Ihara
- Tatsuya Kaji
- Kuniaki Katsui
- Tomoko Miyake
- Takahiro Waki
- Norihisa Katayama
- Hidenobu Matsuzaki
- Osamu Yamasaki
- Masahiro Kuroda
- Shin Morizane
- Susumu Kanazawa
View Affiliations

Affiliations: Department of Radiology, Tsuyama Chuo Hospital, Okayama 708‑0841, Japan, Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan, Department of Proton Beam Therapy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan, Department of Radiology, Okayama University Hospital, Okayama 700‑8558, Japan, Department of Oral Diagnosis and Dentomaxillofacial Radiology, Okayama University Hospital, Okayama 700‑8558, Japan, Department of Radiological Technology, Okayama University Graduate School of Health Sciences, Okayama 700‑8558, Japan
Published online on: September 5, 2019 https://doi.org/10.3892/mco.2019.1918
Pages: 498-504

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cutaneous angiosarcoma is a rare aggressive malignant tumor. Concurrent chemoradiation (CCRT) with maintenance chemotherapy using taxanes is one of the primary treatments. The aim of the present study was to retrospectively analyze the efficacy of CCRT with maintenance chemotherapy using taxanes in localized angiosarcoma of the scalp without cervical lymph node metastases. A total of 19 patients treated with radiation therapy for localized angiosarcomas of the scalp without cervical lymph node metastases were enrolled. The overall survival (OS), progression‑free survival (PFS), and local control (LC) rates were calculated using Kaplan‑Meier analysis. Univariate analyses were performed for various potential prognostic factors for OS, PFS, and LC. The median radiation dose was 70 Gy (range, 60‑70 Gy), and the fractional dose was 2 Gy. Radiation therapy alone, radiation therapy + interleukin‑2, surgery + CCRT with maintenance chemotherapy, CCRT with maintenance chemotherapy, and CCRT without maintenance chemotherapy were administered to 2, 4, 2, 9 and 2 patients, respectively. The 1‑ and 3‑year OS, PFS, and LC rates were 88 and 52%, 47 and 33%, and 74 and 56%, respectively. CCRT with maintenance chemotherapy and surgery were significant prognostic factors for PFS (P=0.036 and 0.025, respectively). Therefore, CCRT with maintenance chemotherapy using taxanes might be effective in treating localized angiosarcomas of the scalp without cervical lymph node metastases.

View Figures

View References

1	Mendenhall WM, Mendenhall CM, Werning JW, Reith JD and Mendenhall NP: Cutaneous angiosarcoma. Am J Clin Oncol. 29:524–528. 2006. View Article : Google Scholar : PubMed/NCBI
2	Bernstein JM, Irish JC, Brown DH, Goldstein D, Chung P, Razak ARA, Catton C, Gilbert RW, Gullane PJ and O'Sullivan B: Survival outcomes for cutaneous angiosarcoma of the scalp versus face. Head Neck. 39:1205–1211. 2017. View Article : Google Scholar : PubMed/NCBI
3	Ward JR, Feigenberg SJ, Mendenhall NP, Marcus RB Jr and Mendenhall WM: Radiation therapy for angiosarcoma. Head Neck. 25:873–878. 2003. View Article : Google Scholar : PubMed/NCBI
4	Shin JY, Roh SG, Lee NH and Yang KM: Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: Systematic review and meta-analysis. Head Neck. 39:380–386. 2017. View Article : Google Scholar : PubMed/NCBI
5	Miki Y, Tada T, Kamo R, Hosono MN, Tamiya H, Shimatani Y, Tsutsumi S, Ogino R and MIKI Y: Single institutional experience of the treatment of angiosarcoma of the face and scalp. Br J Radiol. 86:201304392013. View Article : Google Scholar : PubMed/NCBI
6	Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y and Fujimoto M: Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: A multicentre, retrospective study. Br J Dermatol. 171:1493–1500. 2014. View Article : Google Scholar : PubMed/NCBI
7	Ito T, Uchi H, Nakahara T, Tsuji G, Oda Y, Hagihara A and Furue M: Cutaneous angiosarcoma of the head and face: A single-center analysis of treatment outcomes in 43 patients in Japan. J Cancer Res Clin Oncol. 142:1387–1394. 2016. View Article : Google Scholar : PubMed/NCBI
8	Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, Murakami M, Kawabe T, Ejima Y, Matsumoto A and Sugimura K: Angiosarcoma treated with radiotherapy: Impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys. 52:1032–1040. 2002. View Article : Google Scholar : PubMed/NCBI
9	Ohguri T, Imada H, Nomoto S, Yahara K, Hisaoka M, Hashimoto H, Tokura Y, Nakamura K, Shioyama Y, Honda H, et al: Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys. 61:1446–1453. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, et al: Treatment and prognosis of angiosarcoma of the scalp and face: A retrospective analysis of 48 patients. Br J Radiol. 85:e1127–e1133. 2012. View Article : Google Scholar : PubMed/NCBI
11	Perez MC, Padhya TA, Messina JL, Jackson RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D, et al: Cutaneous angiosarcoma: A single-institution experience. Ann Surg Oncol. 20:3391–3397. 2013. View Article : Google Scholar : PubMed/NCBI
12	Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ and Halyard MY: Angiosarcoma of the scalp and face: The Mayo Clinic experience. JAMA Otolaryngol Head and Neck Surg. 141:335–340. 2015. View Article : Google Scholar
13	Pawlik TM, Paulino AF, Mcginn CJ, Baker LH, Cohen DS, Morris JS, Rees R and Sondak VK: Cutaneous angiosarcoma of the scalp: A multidisciplinary approach. Cancer. 98:1716–1726. 2003. View Article : Google Scholar : PubMed/NCBI
14	Suzuki G, Yamazaki H, Takenaka H, Aibe N, Masui K, Kimoto T, Takekawa K, Nakashima A, Takenaka T, Asai J, et al: Definitive radiation therapy for angiosarcoma of the face and scalp. In Vivo. 30:921–926. 2016. View Article : Google Scholar : PubMed/NCBI
15	Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK and Casper ES: Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 86:2034–2037. 1999. View Article : Google Scholar : PubMed/NCBI
16	Isogai R, Kawada A, Aragane Y and Tezuka T: Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol. 31:335–341. 2004. View Article : Google Scholar : PubMed/NCBI
17	Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T and Nishigori C: Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcoma: Report of 9 patients. Cancer. 110:648–651. 2007. View Article : Google Scholar : PubMed/NCBI
18	Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, et al: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX Study. J Clin Oncol. 26:5269–5274. 2008. View Article : Google Scholar : PubMed/NCBI
19	Van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP, Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI
20	Sindhu S, Gimber LH, Cranmer L, McBride A and Kraft AS: Angiosarcoma treated successfully with anti-PD-1 therapy-a case report. J Immunother Cancer. 5:582017. View Article : Google Scholar : PubMed/NCBI